BioSpace News Archive

Market research firm Technavio has announced the release of their latest report on the global cerebral and tissue oximetry devices market.

Taiyo Pacific Partners announced that it has accumulated in excess of 5% in Sosei Group Corporation (4565) to become Sosei’s second largest shareholder.

SOTIO presented results from its Phase II clinical trials evaluating DCVAC.

Ally Bridge Group (“ABG”), a leading cross-border life science investment group, has completed a Series A investment, as the first part of a total of $50 million raise, in Quantum Surgical, an innovative surgical robotics company in France.

Celgene Corporation announced additional results from RELEVANCE, a phase III, randomized, open-label, international clinical study conducted in partnership with the Lymphoma Academic Research Organisation (LYSARC), were presented at the 54th Annual American Society of Clinical Oncology Scientific Sessions (ASCO).

Market research firm Technavio has announced the release of their latest report on the global fractional flow reserve market.

Jazz Pharmaceuticals plc announced that Xyrem® (sodium oxybate) oral solution, CIII, demonstrated long-term efficacy for up to one year in reducing cataplexy and excessive daytime sleepiness (EDS) in the global Phase 2/3 EXPRESS study of pediatric patients seven to 17 years of age with narcolepsy.

Sensera Inc. is adapting its technology for new applications in bioengineering.